At present, CRP, IL-6, and TNF-α are recognized as representative markers of inflammatory factors in patients with diabetes [50], which can damage EPCs’ function [51], and reduce endothelial regeneration and vascular repair [52]. This evidence concerns the gene CRP and diabetes mellitus.